Delivery Order SPE2DR25D7066-SPE2DR26F7ZTY
Award Date 1/12/26
Potential Completion Date 2/3/26
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,816.32 for 250 mg vials of Ryanodex on July 14, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is funded through the Defense Logistics Agency's Medical Supply Chain, reflecting the government's ongoing need for critical pharmaceutical products to...
- The Defense Logistics Agency awarded a delivery order valued at $3,108.56 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ryanodex 250 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, executed through an open competitive process with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains...
- The Defense Logistics Agency awarded a delivery order valued at $9,632.64 to AmerisourceBergen Drug Corp for Ryanodex 250 mg vials on September 26, 2025, with completion scheduled for October 20, 2025. This firm fixed price, competitively awarded delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The award was placed to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ryanodex 250 mg vials valued at $9,632.64. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ryanodex 250 mg vials, with a ceiling value of $3,210.88 and a completion date of October 3, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to AmerisourceBergen's Corporate Office division, with performance occurring at the company's headquarters in Conshohocken, Pennsylvania. The award is issued under...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $16,010.70 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Ryanodex 250 mg vials. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. This delivery order falls under...
- The U.S. Defense Medical Supply Chain awarded a $52,979.52 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price delivery order is set to conclude on August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,816.32 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 13, 2025, with performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical worth $2,858.20. The order is for the supply of 250 milligram vials of Ryanodex, a pharmaceutical product, to support military treatment programs and facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all items to be delivered by November 17, 2023. No set-aside designation was applied to this order,...